Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB25FYQ16
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,011
Award facts
- Contract value 100% obligated
- $14,010.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a $14,010.78 firm fixed-price delivery order by the Defense Logistics Agency (DLA) for TYMLOS 80 MCG Dose Pen Injector (1.56ML). The award, issued on September 16, 2025, with completion targeted for September 17, 2025, represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026. The contract includes no set-aside designation, allowing the company to compete on the open market while leveraging its woman-owned small business status. Place of performance is Park Ridge, Illinois.
This delivery order supports the DLA's pharmaceutical supply operations for Department of Defense healthcare facilities. TYMLOS (abaloparatide) is a specialized injectable medication used in osteoporosis treatment, reflecting the DLA's need to maintain comprehensive pharmaceutical inventories for military health system requirements. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group regularly fulfills delivery orders for an extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables distributed to military medical facilities nationwide under the DLA's SPE2DB program.
Quick answers
Who was awarded contract SPE2DB25FYQ16?
SPE2DB25FYQ16 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FYQ16 worth?
The government has obligated $14,011 on SPE2DB25FYQ16.
Is contract SPE2DB25FYQ16 an order under another contract?
Yes. SPE2DB25FYQ16 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYQ16 competed?
The extent of competition for SPE2DB25FYQ16 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award